# TG Therapeutics, Inc. (TGTX) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $123M |
| 2024 | $42M |
| 2023 | $21M |
| 2022 | -$218M |
| 2021 | -$345M |
| 2020 | -$274M |
| 2019 | -$169M |
| 2018 | -$174M |
| 2017 | -$119M |
| 2016 | -$79M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | $35M |
| 2025-09-30 | $29M |
| 2025-06-30 | $35M |
| 2025-03-31 | $9M |
| 2024-09-30 | $12M |
| 2024-06-30 | $9M |
| 2024-03-31 | -$9M |
| 2023-09-30 | $115M |
| 2023-06-30 | -$45M |
| 2023-03-31 | -$37M |
| 2022-09-30 | -$35M |
| 2022-06-30 | -$39M |
| 2022-03-31 | -$67M |
| 2021-09-30 | -$85M |
| 2021-06-30 | -$77M |
| 2021-03-31 | -$89M |
| 2020-09-30 | -$86M |
| 2020-06-30 | -$51M |
| 2020-03-31 | -$50M |
| 2019-09-30 | -$61M |
| 2019-06-30 | -$36M |
| 2019-03-31 | -$35M |
| 2018-09-30 | -$34M |
| 2018-06-30 | $44M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/TGTX/operating-income)